ESTRO 2024 - Abstract Book

S2170

Clinical - Upper GI

ESTRO 2024

>65y, n

81 (50.6%)

cT

cT2

18 (11.3%)

135 (84.4%)

cT3

cT4

7 (4.4%)

cN

cN0

7 (4.4%)

cN1

61 (38.1%)

cN2

75 (46.9%)

cN3

17 (10.6%)

Stage

II

7 (4.4%)

IIIA

9 (5.6%)

123 (76.9%)

IIIB

IVA

21 (13.1%)

21.97 (16.43 30.89)

BMI

15.47 (4.8 41.4cm3)

Volume of Gastric fundus

Sex

133 (83.1%)

Male

Female

27 (16.9%)

4cm (1-15 cm)

tumor length

Smoking status

103 (64.4%)

Yes

no

57 (35.6%)

drinking status

yes

98 (61.3%)

no

62 (38.7%)

tumor location

Upper third

21 (13.1%)